Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT02259621
Title Neoadjuvant Anti-PD-1, Nivolumab in Resectable NSCLC
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Sidney Kimmel Comprehensive Cancer Center
Age Groups: adult | senior
Covered Countries USA | CAN

Facility Status City State Zip Country Details
Johns Hopkins at Bayview Medical Center Baltimore Maryland 21224 United States Details
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore Maryland 21287 United States Details
Memorial Sloan Kettering New York New York 10065 United States Details
Swedish Cancer Insitute Edmonds Washington 98026 United States Details
Johnathan Spicer Montréal Quebec H4 3J1 Canada Details
*Shaded cells indicate that there was no data available from for the field